Facebook Linkedin-in Youtube Twitter Instagram
Current Studies
TrueBlue Clinical Research
Current Studies

For Sponsors / CROs

Your Dedicated Research Partner

Ask Us About a Partnership

Our Capabilities

Recruitment:

  • Bilingual (English/Spanish) Recruitment Team
  • Database of 300,00 searchable patients
  • Consistent recruitment rate of 94%
  • Consistent retention rate of over 90%
  • Access to Tampa Bay metro population of > 3 million

Operations:

  • Dedicated and embedded research clinics
  • Multi-therapeutic phase 1b-IV capabilities
  • PPM- CLIA Licensure as well as Local Lab partnerships
  • GCP, OHRP, HIPAA, BLS, ACLS and IATA certified staff

Technology:

  • Part 11 compliant CTMS, eConsent, eRegulatory and eSource systems
  • Virtual study visit capable
  • VersaTrial software for study portal organization and management
  • Experience with most EDC, IWRS/IVRS systems
  • Remote monitoring capable for all studies

Equipment:

  • InTemp WIFI temperature data logger system for ambient, refrigeration and freezer storage
  • Safety equipment includes crash carts, emergency meds, oxygen and defibrillators
  • Laminar flow hood for drug preparation and safety
  • Centrifuges, minus 20 and minus 80 freezers, commercial refrigerators

Therapeutic Areas

Internal Medicine
Infectious Disease
Mental Health
Dermatology
Immunology
AllergyAsthma
Vaccine
Neurology
Devices
TrueBlue Clinical Research

Consistently delivering positive results over a variety of indications.

COVID-19 BOOSTER VACCINE STUDY

Enrollment Goal: 40
Actual Enrollment: 108
0%
Enrollment Rate: 270%
0%
Retention Rate 96%
0%
Enrollment Timeline:
12 Weeks

ACNE VULGARIS STUDY

(Single Site, 3 Locations)
Enrollment Goal: 570
Actual Enrollment: 575
0%
Enrollment Rate: 101%
0%
Retention Rate 90%
0%
Enrollment Timeline:
12 Weeks

ACTINIC KERATOSIS STUDY

Enrollment Goal: 20
Actual Enrollment: 31
0%
Enrollment Rate: 155%
0%
Retention Rate 97%
0%
Enrollment Timeline:
12 Weeks

GLUCOSE MONITOR
DEVICE STUDY

Enrollment Goal: 207
Actual Enrollment: 207
0%
Enrollment Rate: 100%
0%
Retention Rate 100%
0%
Enrollment Timeline:
12 Weeks

TINEA PEDIS STUDY

Enrollment Goal: 25
Actual Enrollment: 31
0%
Enrollment Rate: 124%
0%
Retention Rate 97%
0%
Enrollment Timeline:
10 Weeks

PLAQUE PSORIASIS STUDY

(Pilot study / Rescue Site)
Enrollment Goal: 3
Actual Enrollment: 9
0%
Enrollment Rate: 300%
0%
Retention Rate 100%
0%
Enrollment Timeline:
2 Weeks

Interested in partnerships or sponsorships?

For more information on partnering with TrueBlue Clinical Research, please get in contact with:
George Lott
Business Development Manager

Partnerships

VersaTrial
TrueBlue Clinical Research white
1104 Kyle Wood Lane
Brandon, FL 33511

Phone: (813) 948-7550
Fax: (813) 948-7566
About
Enrolling Studies
Contact
2023 © TrueBlue Clinical Research
Back to Top ^